OKYO Pharma Limited
OKYO
$1.57
-$0.11-6.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 6.26M | 5.55M | 4.84M | 4.67M | 4.49M |
| Gross Profit | -6.26M | -5.55M | -4.84M | -4.67M | -4.49M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.25M | 6.67M | 7.09M | 8.72M | 10.35M |
| Operating Income | -6.25M | -6.67M | -7.09M | -8.72M | -10.35M |
| Income Before Tax | -6.46M | -7.21M | -7.97M | -10.07M | -12.17M |
| Income Tax Expenses | -1.85M | -2.55M | -3.26M | -2.37M | -1.48M |
| Earnings from Continuing Operations | -4.61 | -4.66 | -4.71 | -7.70 | -10.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.61M | -4.66M | -4.71M | -7.70M | -10.69M |
| EBIT | -6.25M | -6.67M | -7.09M | -8.72M | -10.35M |
| EBITDA | -6.25M | -6.67M | -7.09M | -8.72M | -10.35M |
| EPS Basic | -0.11 | -0.12 | -0.12 | -0.22 | -0.32 |
| Normalized Basic EPS | -0.10 | -0.11 | -0.13 | -0.18 | -0.23 |
| EPS Diluted | -0.11 | -0.12 | -0.12 | -0.22 | -0.32 |
| Normalized Diluted EPS | -0.10 | -0.11 | -0.13 | -0.18 | -0.23 |
| Average Basic Shares Outstanding | 165.65M | 161.80M | 157.95M | 145.52M | 133.09M |
| Average Diluted Shares Outstanding | 165.65M | 161.80M | 157.95M | 145.52M | 133.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |